Author
Poorya Najjari Nabi
Bio: Poorya Najjari Nabi is an academic researcher from Tabriz University of Medical Sciences. The author has an hindex of 1, co-authored 1 publications receiving 7 citations.
Papers
More filters
••
TL;DR: In this paper, the authors examined the impact of mucin-1 aptamer-conjugated NPs which were engineered using PAM for image-guided delivery of gefitinib (GEF) in the breast cancer cells/tumor.
31 citations
Cited by
More filters
••
TL;DR: In this article, the authors update the recent progress of antibody nanoconjugates to improve early detection and cancer therapy, which is a critical subject and requires precise design and development.
35 citations
••
TL;DR: In this paper , the basic principles of photodynamic therapy (PDT) and photothermal therapy (PTT) with their strengths and limitations to treat cancers are discussed. And the authors also discuss light-based nanoparticles and their PTT and PDT applications in the preclinical and clinical translation.
28 citations
••
TL;DR: In this paper, a photothermal therapy (PTT) based multifunctional drug delivery platform was proposed to combat breast cancer using gold nanoparticles modified by poly (ethylene glycol) (PEG) to improve their biocompatibility, and the mucin1 (MUC1) aptamer-modified PEG-AuNPs were successfully prepared.
12 citations
••
TL;DR: In this article , a photothermal therapy (PTT) based multifunctional drug delivery platform was proposed for breast cancer. And the authors evaluated the synergistic effect of PTX/[email protected] was evaluated in vitro cell cytotoxicity experiments on MUC1-positive and MUC 1-negative breast cancer cells.
12 citations
••
TL;DR: In this article, a mesoporous silica magnetic nanoparticles (MSMNP) was used as a targeted drug-delivery system for breast cancer cells, which showed promising properties and showed enhanced internalization by folate-receptor-expressing cells.
10 citations